Neurociencias
Département
![Foto de Neurociencias](/img/noimage.png)
![Foto de AstraZeneca (United Kingdom)](/img/noimage_org.png)
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublications en collaboration avec des chercheurs de AstraZeneca (United Kingdom) (7)
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2013
-
Occupational disability in bipolar disorder: Analysis of predictors of being on severe disablement benefit (PREBIS study data)
Acta Psychiatrica Scandinavica, Vol. 127, Núm. 5, pp. 403-411
2012
-
Predictors of recurrence in bipolar disorders in Spain (PREBIS study data)
Journal of Affective Disorders, Vol. 141, Núm. 2-3, pp. 406-414
-
Validación de la versión en castellano de la Escala del Bienestar Subjetivo con Neurolépticos (SWN-K) en pacientes con esquizofrenia
Medicina Clinica, Vol. 138, Núm. 4, pp. 151-154
2008
-
Validity and reliability of the Spanish versions of the Bech-Rafaelsen's mania and melancholia scales for bipolar disorders
Acta Psychiatrica Scandinavica, Vol. 117, Núm. 3, pp. 207-215
2007
-
Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD)
Journal of Affective Disorders, Vol. 102, Núm. 1-3, pp. 93-99
-
The sufficiency of the HAM-D6 as an outcome instrument in the acute therapy of antidepressants in the outpatient setting
International Journal of Psychiatry in Clinical Practice, Vol. 11, Núm. 2, pp. 146-150